GRASSI, SUSANNA
 Distribuzione geografica
Continente #
NA - Nord America 1.255
EU - Europa 728
AS - Asia 244
AF - Africa 49
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 2.283
Nazione #
US - Stati Uniti d'America 1.225
IT - Italia 238
SE - Svezia 214
CN - Cina 140
GB - Regno Unito 88
BG - Bulgaria 68
DE - Germania 59
SG - Singapore 43
CI - Costa d'Avorio 35
CA - Canada 28
VN - Vietnam 27
FI - Finlandia 17
TR - Turchia 17
FR - Francia 15
BE - Belgio 9
IN - India 7
NG - Nigeria 7
HK - Hong Kong 6
SN - Senegal 6
UA - Ucraina 6
NL - Olanda 4
GR - Grecia 3
AU - Australia 2
BR - Brasile 2
ES - Italia 2
EU - Europa 2
KR - Corea 2
PL - Polonia 2
PR - Porto Rico 2
DK - Danimarca 1
ET - Etiopia 1
IE - Irlanda 1
JP - Giappone 1
RO - Romania 1
TW - Taiwan 1
UY - Uruguay 1
Totale 2.283
Città #
Chandler 147
Fairfield 147
Woodbridge 143
Houston 99
Serra 96
Ann Arbor 92
Ashburn 82
Beijing 78
Seattle 68
Sofia 67
Wilmington 49
Cambridge 47
New York 46
Princeton 43
Abidjan 35
Lawrence 27
Ottawa 26
Florence 25
London 24
Medford 24
Bremen 19
Des Moines 17
Izmir 16
Pisa 13
Milan 12
Dearborn 10
Nanjing 10
Brussels 9
San Diego 9
Alessandria 8
Dong Ket 8
Duncan 8
Lagos 7
Redwood City 7
Dakar 6
Hong Kong 6
Los Angeles 6
Rome 6
Hefei 5
Jiaxing 5
Shenyang 5
Boulder 4
Cascina 4
Changsha 4
Frankfurt am Main 4
Hangzhou 4
Hebei 4
Livorno 4
Phoenix 4
Zhengzhou 4
Chiavari 3
Düsseldorf 3
Helsinki 3
Lancaster 3
Nanchang 3
Palermo 3
San Jose 3
Selargius 3
Taranto 3
Anagni 2
Capannori 2
Grafing 2
Jacksonville 2
Kilburn 2
Kunming 2
New Delhi 2
North York 2
Nürnberg 2
Pune 2
San Giuliano Terme 2
Santa Maria A Monte 2
Warsaw 2
Washington 2
Wuhan 2
Addis Ababa 1
Auburn Hills 1
Bangalore 1
Cagliari 1
Chaoyang 1
Chengdu 1
Chicago 1
Chiswick 1
Chongqing 1
Como 1
Copenhagen 1
Cork 1
Delaware 1
Fuzhou 1
Guangzhou 1
Hebburn 1
Horia 1
Indiana 1
Jinan 1
Jüchen 1
Montepulciano 1
Montevideo 1
Mountain View 1
New Bedfont 1
Nuremberg 1
Ogden 1
Totale 1.676
Nome #
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia 135
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 130
TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME 123
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 122
MDS: An Integrated Workup for a Correct Diagnosis 111
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 107
Predictive role of WT1 and RPS14 expression in patients affected by myelodysplastic syndromes receiving azacitidine 101
Droplet digital PCR represents a new sensitive method for detecting B-RAFV600E mutation at diagnosis and during the follow-up of patients affected by hairy cell leukemia 101
LOW RPS14 EXPRESSION IS FREQUENTLY FOUND IN NON-5Q-MYELODYSPLASTIC SYNDROMES 101
The combination of rituximab and bendamustine as first-line treatment is highly effective in the eradicating minimal residual disease in follicular lymphoma: An Italian retrospective study 97
Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup 95
The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia 95
WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes 91
Low RPS14 expression negatively conditions the prognosis of patients affected by not 5q- myelodysplastic syndromes during azacitidine treatment 90
Donor-transmitted Triple-Hit Lymphoma in a Renal Allograft Recipient 79
Myelodysplastic Syndromes: A Multidisciplinary Integrated Diagnostic Work-up for Patients' Risk Stratification 76
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients 70
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EOSINOPHILOIA IN EGPA FROM HES 69
Conventional Cytogenetics, ACGH, and PCR as Integrated Workup for a Correct Diagnosis of MDS 67
THE C.480C>G POLYMORPHISM OF HOCT1 TRANSPORTER INFLUENCES IMATINIB CLEARANCE IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA 65
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice 65
R-IPSS, RPS14 AND WT1 LEVELS ARE THE BEST PROGNOSTIC FACTORS FOR PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROMES DURING AZACITIDINE TREATMENT. 64
Altered Expression of Jak-Stat Pathway as Possible Predictive Marker in Patients Affected by Chronic Myeloid Leukemia Receiving Tyrosin Kinase Inhibitors (TKIS) 63
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network 62
Digital droplet PCR is a specific and sensitive tool for detecting IDH2 mutations in acute myeloid leukemia patients 52
Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation 48
TYROSINE KINASE INHIBITORS SIGNIFICANTLY CHANGE THE EXPRESSION OF POLYCOMB GENES IN CHRONIC MYELOID LEUKEMIA 44
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma 40
Totale 2.363
Categoria #
all - tutte 6.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201969 0 0 0 0 0 0 0 0 0 0 33 36
2019/2020523 47 31 66 23 40 58 41 34 37 62 45 39
2020/2021204 11 9 5 5 10 17 24 11 24 14 34 40
2021/2022364 18 10 2 13 55 47 13 8 48 20 31 99
2022/2023545 89 110 33 50 47 45 5 49 80 6 30 1
2023/2024219 14 22 43 13 35 46 17 10 1 18 0 0
Totale 2.363